Versatope Therapeutics
Versatope Therapeutics is a clinical-stage biotechnology company based in Lowell, MA, that focuses on leveraging designer extracellular nano-vesicles to enhance immunity against infectious diseases such as influenza and malaria, while also targeting therapeutics for cancer. Their innovative platform utilizes molecular engineering to create Recombinant Extracellular Transport Vesicles (RET-Vs), enabling the display of multiple viral variants on a single vesicle for more effective vaccine development.
By employing this cutting-edge technology, Versatope aims to provide cross-strain immunity, protect against emerging strains, and deliver therapeutic RNA directly into cancer cells, thereby revolutionizing immunotherapy. Their approach emphasizes rapid synthesis, scalability, and the thermostability of their vaccine solutions, positioning them competitively in the field of vaccine and therapeutic development.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
